Across the recent three months, 4 analysts have shared their insights on Theravance Biopharma (NASDAQ:TBPH), expressing a variety of opinions spanning from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 0 | 2 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 1 | 0 | 2 | 0 | 0 |
3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $12.25, with a high estimate of $15.00 and a low estimate of $9.00. A 18.33% drop is evident in the current average compared to the previous average price target of $15.00.
Decoding Analyst Ratings: A Detailed Look
A clear picture of Theravance Biopharma's...
ログインすると全部閲覧できます。
ログイン